Cargando…

Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection

BACKGROUND: Interleukin (IL)-35 regulates imbalance between regulatory T cells (Tregs) and T helper (Th) 17 cells, leading to an important modulator in autoimmune disorder, cancer, and infectious diseases. Our previous study revealed an immunosuppressive activity of IL-35 in chronic hepatitis B viru...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lanlan, Jia, Shengnan, Shao, Xue, Liu, Siqi, Zhang, Qian, Song, Jie, Wang, Wudong, Jin, Zhenjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469219/
https://www.ncbi.nlm.nih.gov/pubmed/30992023
http://dx.doi.org/10.1186/s12985-019-1158-0
_version_ 1783411603290456064
author Yang, Lanlan
Jia, Shengnan
Shao, Xue
Liu, Siqi
Zhang, Qian
Song, Jie
Wang, Wudong
Jin, Zhenjing
author_facet Yang, Lanlan
Jia, Shengnan
Shao, Xue
Liu, Siqi
Zhang, Qian
Song, Jie
Wang, Wudong
Jin, Zhenjing
author_sort Yang, Lanlan
collection PubMed
description BACKGROUND: Interleukin (IL)-35 regulates imbalance between regulatory T cells (Tregs) and T helper (Th) 17 cells, leading to an important modulator in autoimmune disorder, cancer, and infectious diseases. Our previous study revealed an immunosuppressive activity of IL-35 in chronic hepatitis B virus (HBV) infection. Thus, the aim of the current study was to investigate the role of regulatory function of IL-35 to viral specific Tregs/Th17 cells balance in chronic HBV infection. METHODS: A total of 44 HLA-A2 restricted chronic HBV infected patients, including 21 of chronic hepatitis B (CHB) and 23 of asymptomatic HBV carriers (ASC) were enrolled. Purified CD4(+) T cells or CD4(+)CD25(+)CD127(dim/−) Tregs were stimulated with recombinant IL-35. HBV core antigen specific Tregs and Th17 cells were determined by flow cytometry. FoxP3 and RORγt mRNA was measured by real-time PCR. Cytokines production (IL-10 and IL-17) was investigated by ELISA. RESULTS: Peripheral viral specific Tregs was comparable between CHB and ASC. However, increased percentage of viral specific Th17 cells was found in CHB, leading to the reduction of Tregs/Th17 ratio in CHB patients. IL-35 stimulation elevated viral specific Tregs, but not Th17 cells frequency, in both CHB and ASC, resulting in the elevation of Tregs/Th17 ratio in both groups. This process was accompanied by increased expression of FoxP3 mRNA and IL-10 production, and decreased IL-17 secretion and STAT3 phosphorylation in purified CD4(+) T cells. Moreover, IL-35 stimulation inhibited viral specific Th17-like phenotype differentiation from Tregs in CHB patients. Effective anti-HBV therapy did not affect viral specific Tregs/Th17 cells frequency or IL-35 expression in CHB patients, however, reduced responsiveness of CD4(+) T cells or Tregs to IL-35 stimulation in vitro. CONCLUSION: Our findings indicated that IL-35 regulation to viral specific Tregs/Th17 balance may contribute to viral persistence in chronic HBV infection.
format Online
Article
Text
id pubmed-6469219
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64692192019-04-24 Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection Yang, Lanlan Jia, Shengnan Shao, Xue Liu, Siqi Zhang, Qian Song, Jie Wang, Wudong Jin, Zhenjing Virol J Research BACKGROUND: Interleukin (IL)-35 regulates imbalance between regulatory T cells (Tregs) and T helper (Th) 17 cells, leading to an important modulator in autoimmune disorder, cancer, and infectious diseases. Our previous study revealed an immunosuppressive activity of IL-35 in chronic hepatitis B virus (HBV) infection. Thus, the aim of the current study was to investigate the role of regulatory function of IL-35 to viral specific Tregs/Th17 cells balance in chronic HBV infection. METHODS: A total of 44 HLA-A2 restricted chronic HBV infected patients, including 21 of chronic hepatitis B (CHB) and 23 of asymptomatic HBV carriers (ASC) were enrolled. Purified CD4(+) T cells or CD4(+)CD25(+)CD127(dim/−) Tregs were stimulated with recombinant IL-35. HBV core antigen specific Tregs and Th17 cells were determined by flow cytometry. FoxP3 and RORγt mRNA was measured by real-time PCR. Cytokines production (IL-10 and IL-17) was investigated by ELISA. RESULTS: Peripheral viral specific Tregs was comparable between CHB and ASC. However, increased percentage of viral specific Th17 cells was found in CHB, leading to the reduction of Tregs/Th17 ratio in CHB patients. IL-35 stimulation elevated viral specific Tregs, but not Th17 cells frequency, in both CHB and ASC, resulting in the elevation of Tregs/Th17 ratio in both groups. This process was accompanied by increased expression of FoxP3 mRNA and IL-10 production, and decreased IL-17 secretion and STAT3 phosphorylation in purified CD4(+) T cells. Moreover, IL-35 stimulation inhibited viral specific Th17-like phenotype differentiation from Tregs in CHB patients. Effective anti-HBV therapy did not affect viral specific Tregs/Th17 cells frequency or IL-35 expression in CHB patients, however, reduced responsiveness of CD4(+) T cells or Tregs to IL-35 stimulation in vitro. CONCLUSION: Our findings indicated that IL-35 regulation to viral specific Tregs/Th17 balance may contribute to viral persistence in chronic HBV infection. BioMed Central 2019-04-16 /pmc/articles/PMC6469219/ /pubmed/30992023 http://dx.doi.org/10.1186/s12985-019-1158-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yang, Lanlan
Jia, Shengnan
Shao, Xue
Liu, Siqi
Zhang, Qian
Song, Jie
Wang, Wudong
Jin, Zhenjing
Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection
title Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection
title_full Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection
title_fullStr Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection
title_full_unstemmed Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection
title_short Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection
title_sort interleukin-35 modulates the balance between viral specific cd4(+)cd25(+)cd127(dim/-) regulatory t cells and t helper 17 cells in chronic hepatitis b virus infection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469219/
https://www.ncbi.nlm.nih.gov/pubmed/30992023
http://dx.doi.org/10.1186/s12985-019-1158-0
work_keys_str_mv AT yanglanlan interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection
AT jiashengnan interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection
AT shaoxue interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection
AT liusiqi interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection
AT zhangqian interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection
AT songjie interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection
AT wangwudong interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection
AT jinzhenjing interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection